LACK OF EFFECT OF TREATMENT WITH HUMAN RECOMBINANT-TUMOR NECROSIS FACTOR (HRTNF) ON THE BINDING OF QUINIDINE TO ALPHA-1-ACID GLYCOPROTEIN (AGP)

被引：4

作者：

BARNETT, JA

BRENNER, DE

CREAVEN, PJ

LALKA, D

机构：

[1] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260

[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL & THERAPEUT,BUFFALO,NY 14263

[3] SUNY BUFFALO,DEPT MED,BUFFALO,NY 14260

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 27卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb05358.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：257 / 261

页数：5

共 21 条

[1]

CREAVEN PJ, 1987, CANCER CHEMOTH PHARM, V20, P137

[2] MONOCYTE-CONDITIONED MEDIUM, INTERLEUKIN-1, AND TUMOR-NECROSIS-FACTOR STIMULATE THE ACUTE PHASE RESPONSE IN HUMAN HEPATOMA-CELLS INVITRO [J].

DARLINGTON, GJ ;

WILSON, DR ;

LACHMAN, LB .

JOURNAL OF CELL BIOLOGY, 1986, 103 (03) :787-793

[3]

DERICK AF, 1987, J PHARMACOL EXP THER, V241, P289

[4] CURRENT CONCEPTS - LYMPHOKINES [J].

DINARELLO, CA ;

MIER, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15) :940-945

[5]

DRAYER DE, 1977, J LAB CLIN MED, V90, P816

[6] LACK OF EFFECT OF SMOKING ON THE METABOLISM AND PHARMACOKINETICS OF QUINIDINE IN PATIENTS [J].

EDWARDS, DJ ;

AXELSON, JE ;

VISCO, JP ;

VANEVERY, S ;

SLAUGHTER, RL ;

LALKA, D .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (03) :351-354

[7] ALPHA-1-ACID GLYCOPROTEIN CONCENTRATION AND PROTEIN-BINDING IN TRAUMA [J].

EDWARDS, DJ ;

LALKA, D ;

CERRA, F ;

SLAUGHTER, RL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (01) :62-67

[8] FACTORS AFFECTING QUINIDINE PROTEIN-BINDING IN HUMANS [J].

EDWARDS, DJ ;

AXELSON, JE ;

SLAUGHTER, RL ;

ELVIN, AT ;

LALKA, D .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (09) :1264-1267

[9] DISPLACEMENT OF LIDOCAINE FROM SERUM ALPHA-1-ACID GLYCOPROTEIN BINDING-SITES BY BASIC DRUGS [J].

GOOLKASIAN, DL ;

SLAUGHTER, RL ;

EDWARDS, DJ ;

LALKA, D .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (03) :413-417

[10]

Gresser I, 1987, J Biol Regul Homeost Agents, V1, P173

← 1 2 3 →